Literature DB >> 16515098

Treatment of Miller Class III recessions with enamel matrix derivative (Emdogain) in combination with subepithelial connective tissue grafting.

Shuichi Sato1, Kiyoshi Yamada, Takashi Kato, Kotaro Haryu, Koichi Ito.   

Abstract

This report examines the clinical parameters and radiographic characteristics of two patients with Class III gingival recession who were treated with combined connective tissue grafting and root coverage with enamel matrix derivative. Both patients presented with multiple Class III recessions in the mandibular central incisors. Root coverage was achieved by connective tissue grafting in conjunction with the application of enamel matrix derivative. Soft tissue coverage of the root surfaces was achieved clinically, and radiographs showed improvement in the interproximal vertical bone defects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16515098

Source DB:  PubMed          Journal:  Int J Periodontics Restorative Dent        ISSN: 0198-7569            Impact factor:   1.840


  3 in total

1.  Split-mouth evaluation of connective tissue graft with or without enamel matrix derivative for the treatment of isolated gingival recession defects in dogs.

Authors:  Y Shirakata; T Nakamura; Y Shinohara; K Nakamura-Hasegawa; C Hashiguchi; N Takeuchi; T Imafuji; A Sculean; K Noguchi
Journal:  Clin Oral Investig       Date:  2018-12-01       Impact factor: 3.573

2.  Effect of enamel matrix derivative on wound healing following gingival recession coverage using the modified coronally advanced tunnel and subepithelial connective tissue graft: a randomised, controlled, clinical study.

Authors:  Alexandra Stähli; Jean-Claude Imber; Elena Raptis; Giovanni E Salvi; Sigrun Eick; Anton Sculean
Journal:  Clin Oral Investig       Date:  2019-07-09       Impact factor: 3.573

3.  Complete root coverage in the treatment of Miller class III or RT2 gingival recessions: a systematic review and meta-analysis.

Authors:  Aitziber Fernández-Jiménez; Ana-María García-De-La-Fuente; Ruth Estefanía-Fresco; Xabier Marichalar-Mendia; José-Manuel Aguirre-Urizar; Luis-Antonio Aguirre-Zorzano
Journal:  BMC Oral Health       Date:  2021-03-22       Impact factor: 2.757

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.